Xylem (NYSE:XYL) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. initiated coverage on shares of Xylem (NYSE:XYL - Get Free Report) in a research report issued to clients and investors on Friday, Marketbeat.com reports. The firm set an "overweight" rating and a $148.00 price target on the industrial products company's stock. JPMorgan Chase & Co.'s price target indicates a potential upside of 17.51% from the stock's previous close.

A number of other analysts also recently issued reports on the stock. Robert W. Baird lowered their price objective on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a report on Wednesday, April 30th. Stifel Nicolaus upped their price objective on shares of Xylem from $140.00 to $141.00 and gave the company a "buy" rating in a report on Wednesday, April 30th. Raymond James raised shares of Xylem to a "hold" rating in a research report on Thursday, May 15th. Royal Bank of Canada upped their price objective on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Finally, Citigroup cut their price objective on shares of Xylem from $152.00 to $134.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $143.71.

Xylem Trading Up 0.2%

Xylem stock traded up $0.29 during midday trading on Friday, hitting $125.95. 2,624,076 shares of the stock were exchanged, compared to its average volume of 1,404,432. The company has a quick ratio of 1.33, a current ratio of 1.76 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $30.65 billion, a PE ratio of 34.41, a P/E/G ratio of 2.33 and a beta of 1.10. The company has a fifty day simple moving average of $118.04 and a two-hundred day simple moving average of $121.55. Xylem has a 52 week low of $100.47 and a 52 week high of $143.50.

Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.95 by $0.08. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.04 billion. During the same period last year, the company posted $0.90 EPS. The business's quarterly revenue was up 1.8% on a year-over-year basis. Equities research analysts anticipate that Xylem will post 4.65 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in XYL. Vanguard Group Inc. increased its position in Xylem by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company's stock valued at $3,465,122,000 after purchasing an additional 362,127 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Xylem by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock worth $671,623,000 after purchasing an additional 135,492 shares in the last quarter. Impax Asset Management Group plc lifted its holdings in shares of Xylem by 231.5% in the 4th quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company's stock worth $644,039,000 after purchasing an additional 3,883,845 shares in the last quarter. Royal Bank of Canada lifted its holdings in shares of Xylem by 7.9% in the 4th quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock worth $506,985,000 after purchasing an additional 320,500 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Xylem by 7.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company's stock valued at $480,767,000 after buying an additional 274,123 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.